VVC and GPS: Interest of Ultrasound Coupled to a Guidance System (GPS) for Central Venous Catheters (CVC) Insertion.

Sponsor
University Hospital, Grenoble (Other)
Overall Status
Completed
CT.gov ID
NCT02231528
Collaborator
(none)
100
1
2
11
9.1

Study Details

Study Description

Brief Summary

The GPS system would simplify the technical implementation of central venous catheter under ultrasound guidance. We can assume that the introduction of deep venous pathways (as a reference, the internal jugular) will be faster, and this, whatever the level of expertise. By checking this hypothesis, this technique could be applied to much less frequent situations establishment of difficult central venous catheters (hemodynamic status precarious, hypovolemia, or cardiac arrest).

The main objective of this study is to evaluate the time savings provided by the ultrasound assisted GPS guidance for installing central venous catheters in the internal jugular. Central venous catheters are inserted in the operating room under conditions scheduled in advance that is to say outside emergency. The installation time for the central venous catheter is compared with that obtained by using the ultrasound machine without the GPS guide ("conventional" technique).

Condition or Disease Intervention/Treatment Phase
  • Device: Use of ultrasound with active GPS
  • Device: Use of ultrasound with inactive GPS
Phase 3

Detailed Description

The techniques of reference for the central venous access (internal jugular, subclavian or femoral) are based on anatomical landmarks and the low probability of anatomical variations. With these techniques, the central venous puncture, with Seldinger method, is associated to complications both in adults and in children (pneumothorax, hemothorax, infection, thrombosis, arterial puncture, inappropriate location). The frequency of these adverse events is highly variable and ranges between 1 and 20% of central venous catheters in place. Ultrasound, visualizing anatomical structures before (echo tracking) or during (ultrasound guidance) the puncture, improves about 80% the success of the first puncture, and decreases by 50% the complications. The ultrasound guidance is better than echo tracking to reduce the time of implementation of the central venous catheter. However, this technique requires more practice. On the other hand, visualization of the needle path is not always easy especially for the subclavian access, because it requires a puncture in the ultrasound plane.

GPS system (Guidance Positioning System) is an original system of guidance. This is a simple navigation system for projecting the theoretical position of the puncture needle in the ultrasound plane. The guidance system consists of a receiver and two motion sensors. The receiver is connected to the system. A motion sensor is incorporated into the end of the needle. Another motion sensor is located within the ultrasound probe. The relative positions and the axes of the needle and the ultrasound probe are transmitted with coordinates in three dimensions.

The puncture can be carried out of the plane (ultrasound probe perpendicular to the axis puncture) and the direct visualization of the needle is not necessary. Before the puncture, the end of the needle is placed on the skin. The direction and the axis of the needle relative to the skin are adjusted, before the puncture, depending on the position of the target to be achieved, displayed by a mark on the screen. Throughout the puncture, a projected image of the needle is displayed on the screen.

Study Design

Study Type:
Interventional
Actual Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Official Title:
Interest of Ultrasound Coupled to a Guidance System (GPS) for Central Venous Catheters (CVC) Insertion.
Study Start Date :
Oct 1, 2013
Actual Primary Completion Date :
Sep 1, 2014
Actual Study Completion Date :
Sep 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Use of ultrasound with active GPS

Device: Use of ultrasound with active GPS
CVC insertion with ultrasound with active GPS function and appropriate needles

Active Comparator: Use of ultrasound with inactive GPS

Device: Use of ultrasound with inactive GPS
CVC insertion with ultrasound with inactive GPS function and conventional needles

Outcome Measures

Primary Outcome Measures

  1. Time required for CVC insertion [at the end of the insertion of the guide wire, an average of one and a half minutes after the beginning of the procedure]

Secondary Outcome Measures

  1. Total number of puncture [at the end of the insertion of the guide wire, an average of one and a half minutes after the beginning of the procedure]

  2. Complication rate in the superior vena cava territory [At 24 hours]

    Complication rate secondary to cannulation in the territory superior vena cava: arterial puncture, subcutaneous hematoma, pneumothorax, difficulty progression of the guide, aberrant pathway, transfixion of the vein

  3. Insertion failure rate [at the end of the insertion of the guide wire, an average of one and a half minutes after the beginning of the procedure]

    Failure is defined as the necessity to change anatomical site despite the visualization of the vein or stop using the GPS function

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adults 2 sexes

  • Age> 18years

  • Indication for placing a central venous catheter in internal jugular

  • Scheduled installation

Exclusion Criteria:
  • Persons referred to in Articles L. 1121-5 to L. 1121-8 Code of Public Health,

  • Lack of coverage by social security

  • Refusal of patient consent

  • Contraindication for placement of a central venous catheter in internal jugular

  • Emergency

  • Pregnancy

  • Doppler data from the supra-aortic trunks if it exists (eg bilateral carotid stenosis)

  • Pacemaker, defibrillator

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU de Grenoble Grenoble France 38043

Sponsors and Collaborators

  • University Hospital, Grenoble

Investigators

  • Principal Investigator: Pierre ALBALADEJO, MD, University Hospital, Grenoble

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University Hospital, Grenoble
ClinicalTrials.gov Identifier:
NCT02231528
Other Study ID Numbers:
  • 1230
First Posted:
Sep 4, 2014
Last Update Posted:
Jun 2, 2015
Last Verified:
Jun 1, 2015
Keywords provided by University Hospital, Grenoble

Study Results

No Results Posted as of Jun 2, 2015